Apollomics, Inc. (APLM) compared with its closest peers (KPTI, SILO, VERU, PDSB, CRVO). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | $44.57M | -0.4 |
| Silo Pharma, Inc. (SILO) | $43.59M | — |
| Veru Inc. (VERU) | $42.37M | -2.4 |
| PDS Biotechnology Corporation (PDSB) | $40.23M | — |
| CervoMed Inc. (CRVO) | $39.61M | -2.6 |
| Actinium Pharmaceuticals, Inc. (ATNM) | $34.90M | 3.0 |
| Lite Strategy, Inc. (LITS) | $34.02M | — |
| MIRA Pharmaceuticals, Inc. (MIRA) | $33.62M | -1.1 |
| Actuate Therapeutics Inc (ACTU) | $32.54M | -5.8 |
| IGC Pharma, Inc. (IGC) | $31.49M | -5.6 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.0 |
APLM overview · APLM earnings · APLM financials · APLM KPIs · APLM investor relations · APLM ownership · APLM filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.